Approaches for modeling within subject variability in pharmacometric count data analysis: dynamic inter-occasion variability and stochastic differential equations

scientific article

Approaches for modeling within subject variability in pharmacometric count data analysis: dynamic inter-occasion variability and stochastic differential equations is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043006578
P356DOI10.1007/S10928-016-9473-1
P8608Fatcat IDrelease_ycxu6djjofhuljyqal74slkm34
P698PubMed publication ID27165151

P50authorMats O KarlssonQ88464853
P2093author name stringElodie L Plan
Chenhui Deng
P2860cites workStochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.Q48947411
A pharmacodynamic Markov mixed-effects model for determining the effect of exposure to certolizumab pegol on the ACR20 score in patients with rheumatoid arthritisQ84278833
Modeling and simulation of count dataQ30842267
PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.Q33219671
Modelling overdispersion and Markovian features in count dataQ33508253
Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure componentsQ34156372
Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analoguesQ36024462
An integrated model for the effect of budesonide on ACTH and cortisol in healthy volunteersQ36024571
Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and XposeQ41454681
Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysisQ42607912
Pharmacokinetic/pharmacodynamic modeling of luteinizing hormone (LH) suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal womenQ44362844
Grey-box pharmacokinetic/pharmacodynamic modelling of a euglycaemic clamp studyQ44911396
The importance of modeling interoccasion variability in population pharmacokinetic analysesQ46317518
Likert pain score modeling: a Markov integer model and an autoregressive continuous modelQ47999794
P433issue3
P921main subjectdata analysisQ1988917
P304page(s)305-314
P577publication date2016-05-10
P1433published inJournal of Pharmacokinetics and PharmacodynamicsQ15766045
P1476titleApproaches for modeling within subject variability in pharmacometric count data analysis: dynamic inter-occasion variability and stochastic differential equations
P478volume43

Reverse relations

cites work (P2860)
Q36332317A big data approach to the development of mixed-effects models for seizure count data.
Q89134402Assessment of components included in published societal perspective or QALY outcome economic analyses for antiepileptic drug treatment in chronic epilepsy
Q90703319Exact Gradients Improve Parameter Estimation in Nonlinear Mixed Effects Models with Stochastic Dynamics
Q90329530Natural variability in seizure frequency: Implications for trials and placebo
Q47705677Pharmacometrics models with hidden Markovian dynamics

Search more.